In this review:
A new method for assessing global risk of AD
A brief screening tool for mild cognitive impairment
AD biomarkers predict cognitive impairment
Genetic screening for AMCI may be economically attractive
Ginkgo biloba is not effective for prevention of AD
Active Aβ immunotherapy with CAD106 looks promising
NSAIDs have variable effects on cognitive decline
Ten years of donepezil clinical use reviewed
Management of agitation and aggression in people with AD
Yogic meditation benefits family dementia caregivers
Please login below to download this issue (PDF)